TPG Growth, the middle market and growth equity platform of alternative asset firm TPG, has made a significant minority investment in AnovoRx Holdings (Anovo), a provider of specialty pharmacy services and customised treatment and support programs that address the unique needs of patients with certain complex and chronic diseases.
TPG is a global healthcare investor and has made numerous growth stage investments across the sector. Those transactions include BGB Group, Implantable Provider Group, Pharmeasy, Stelis Biopharma, and Vasaragen.
Read more/Source: Private Equity Wire
